Established | 1990 - Facility opened Fall 1995 |
---|---|
Parent institution
|
University of Florida |
Budget | $600,000 per year (2014) |
Director |
Mark S. Long 'Assistant director Merrie A. Shaw |
Location | Alachua, Florida, United States |
Website | sidmartinbio.org |
Mark S. Long
The University of Florida's Sid Martin Biotechnology Incubator is located in Alachua, Florida, in Progress Park. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the University. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.
As of 2014[update], the facility had an annual budget of $600,000, of which ⅓ came from the University of Florida and the balance from fees paid by resident companies.
The Sid Martin Biotechnology Development Institute (SMBI) was officially founded on July 2, 1990 by the Florida Legislature. It was named after Sid Martin, a member of the Florida House of Representatives, in recognition of his commitment to the state of Florida and the University of Florida. In 1994, the Trustees at the University of Florida authorized 6 acres (24,000 m2) to build the Sid Martin Biotech Incubator.
The Incubator is 40,000 square feet (3,700 m2) and was built with a combination of funding from the University of Florida, the United States Department of Agriculture, and the Florida Legislature. The facility was created, engineered, equipped, and opened in 1995 as one of the first bio-business incubators in the United States. Approximate cost at that time was $11.5 million. The facility is located just outside Gainesville, Florida in the Progress Corporate Park. Much of this research park was a product of the vision of former University of Florida President, Robert Q. Marston.
Over 60 biotechnology startups have graduated from SMBI and become self-sufficient companies or were acquired. Among them are:
In 2004[update], the facility's Director was reported to be David L. Day. By 2014[update], this role had been conferred upon Patti Breedlove.